<DOC>
	<DOCNO>NCT01021488</DOCNO>
	<brief_summary>Deep vein thrombosis ( DVT ) devastate disease influence mortality morbidity patient at-risk like undergo orthopedic surgery . Recent publication suggest HMO-co-A reductase inhibitor ( statin ) may reduce occurrence rate venous thromboembolism apparently healthy person . The pleiotropic property statin like antioxidant , antithrombotic , anti-inflammatory may effect positive result . We investigate whether rosuvastatin associate low incidence deep vein thrombosis ( DVT ) patient undergo total knee replacement arthroplasty ( TKRA ) at-high risk develop DVT</brief_summary>
	<brief_title>Rosuvastatin Preventing Deep Vein Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients go receive total knee replacement arthroplasty cause . &lt; 19 year old patient cancer Patients receive anticoagulant agent cause current statin user expect survival comorbidity &lt; 1year Bed ridden patient AST , ALT &gt; 3times upper normal limit CK &gt; upper normal limit pregnancy patient receive hormone replacement therapy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Thrombosis</keyword>
	<keyword>Vein</keyword>
	<keyword>Statin</keyword>
	<keyword>Prevention</keyword>
</DOC>